Renaissance Capital logo

Aratana Therapeutics Priced, Nasdaq: PETX

Developing medications for cats and dogs based on therapies for humans.

Industry: Health Care

First Day Return: +37.7%

Industry: Health Care

Developing medications for cats and dogs based on therapies for humans.
more less

Aratana Therapeutics (PETX) Performance